Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

How should I address risk factors when discussing osteoarthritis prevention with patients?

  • Comment

This article will tell you about:

  • What osteoarthritis (OA) is, its prevalence, and risk factors for development
  • Diagnosis of OA based on its effects on bone, cartilage and other components of synovial joints
  • The physiological process by which inflammation and pain are created
  • The roles of specific neurotransmitters in the pathophysiology of OA

You would be likely to reference this article if you were researching:

  • Osteoarthritis
  • Neurotransmitters and processes of pain and inflammation
  • Central sensitisation

In what situations will this article be useful to me?

This article will be useful to you in understanding osteoarthritis. You may care for patients specifically because of their OA or it may be additional to the condition that they are being treated for. This article covers a wide range of topics, including diagnosis, causes of pain, and chemical mediators. An understanding of the pathophysiology (pain, inflammation) presented will be important in treating patients. Discussion of risk-factors and prevalence with patients could also be useful in decreasing the chance of developing and controlling symptoms.

Questions for your mentor/tutor:

  • How can an understanding of the pathophysiology of osteoarthritis improve my ability to care for patients?
  • How should I address risk factors in discussion with patients for the prevention of osteoarthritis?

Student NT Decoder:

Osteoarthritis (OA): a synovial joint disorder involving cartilage, bone and the synovial membrane. Diagnosed from a persistent history of pain, stiffness and loss of function. OA is different from Rheumatoid arthritis (RA), and one key distinguishing factor is the degree of inflammation. In OA, inflammation is generally less. Both OA and RA affect synovial joints.

Neurotransmitter: a chemical signal that transmits a message from one neuron to a target cell across a synapse (for example glutamate).

Nociceptor: a sensory nerve receptor that responds to damaging or potentially damaging stimulation (chemical, thermal or mechanical).

Synovium: also known as the synovial membrane. It is a layer of tissues a few cells thick that lines the joint and the tendon sheath. It protects the joint by acting as a selective barrier and produces lubrication for the joint.

Other articles you might find useful:

  • Rheumatoid arthritis 1: background, symptoms and ensuring prompt diagnosis and treatment
  • The management of osteoarthritis and rheumatoid arthritis
  • New guidance on osteoarthritis focuses on patient education
  • Comment

Have your say

You must sign in to make a comment.

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.